Back to Results
First PageMeta Content
Microbiology / Extensively drug-resistant tuberculosis / Multi-drug-resistant tuberculosis / Tuberculosis treatment / Directly Observed Therapy – Short Course / Isoniazid / AIDS / 4-Aminosalicylic acid / Rifampicin / Tuberculosis / Medicine / Health


MAJOR ARTICLE Extensively Drug-Resistant Tuberculosis in California, 1993–2006 Ritu Banerjee,1 Jennifer Allen,2 Janice Westenhouse,2 Peter Oh,2 William Elms,2 Ed Desmond,3 Annette Nitta,4 Sarah Royce,2 and Jennifer Fl
Add to Reading List

Document Date: 2014-02-28 13:01:15


Open Document

File Size: 211,93 KB

Share Result on Facebook

City

Geneva / Los Angeles / Natal / /

Company

Rivera AB / Duse AG / Public Health Microbial Diseases Laboratory / Microbial Diseases Laboratory / XDR TB / 3Microbial Diseases Laboratory / /

Continent

Asia / /

Country

Switzerland / Mexico / Iran / Latvia / South Africa / Norway / United States / Vietnam / Korea / Philippines / China / South Korea / India / /

Currency

USD / /

/

Event

M&A / Natural Disaster / /

Facility

TB laboratory / SAS Institute / University of California / /

IndustryTerm

State law / evaluable / /

MedicalCondition

United Extensively Drug-Resistant Tuberculosis / TB / JE / HIV / M. tuberculosis / Initial M. tuberculosis / Other Prior tuberculosis diagnosis Pulmonary disease / strain / protracted infectious period / XDR TB / MDR TB / infectious periods / DISCUSSION Although XDR TB / Mycobacterium tuberculosis infection / acquired XDR TB / extrapulmonary disease / cavitary lung disease / XDR-TB / Drug-Resistant Tuberculosis / HIV infection / extensively drugresistant tuberculosis / resistant tuberculosis / multidrugresistant tuberculosis / disease / Div. of Infectious Disease / ARTICLE Extensively Drug-Resistant Tuberculosis / Mycobacterium tuberculosis / pulmonary disease / XDR / Clinical Infectious Diseases / terminal illness / AIDS / cavitary disease / single XDR TB / Extensively Drug-Resistant Tuberculosis / multidrug-resistant Mycobacterium tuberculosis / each XDR TB / Tuberculosis / /

MedicalTreatment

antibiotics / directly observed therapy / /

Organization

World Health Organization / Division of Infectious Disease / Department of Pediatrics / Infectious Diseases Society of America / Centers for Disease Control and Prevention / SAS Institute / California Department of Public Health Microbial Diseases Laboratory / University of California / San Francisco / Department of Health / /

Person

MDR TB / Ritu Banerjee / Lisa Pascopella / Desmond E. Rapid / Henry F. Chambers / /

/

Position

Fisher / /

Product

kanamycin / ofloxacin / Incarcerated Injection / isoniazid / F15 / rifampin / Pyrazinamide / INH / ciprofloxacin / /

ProvinceOrState

California / /

PublishedMedium

Clinical Infectious Diseases / /

Region

South Korea / /

Technology

genotyping / drug development / /

URL

http /

SocialTag